EVENTS

Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.

The 2018 programme offers delegates a dynamic programme of case-study presentations, interactive panel discussions and workshops and networking breaks which will enable the audience to take away practical strategies that can be used to improve the efficiency of their clinical supply chains.

2018 Agenda Highlights:
•    Interactive panel: Debating the efficiencies of comparator and placebo controlled trials
•    Uncovering border control requirements to ensure your trial drug reaches their destination without delays
•    Using and advancing the use of Artificial Intelligence(AI) as a tool facilitating clinical trial operations and improve efficiency in clinical supply
•   Assessing the use of IVRS systems for small pharma companies as an integrated platform facilitating communication and streamlining projects
•    Maintaining the temperature of increasing large molecule and protein-based therapies market in the Bay area to avoid product loss and the consequent costs incurred

2018 Key Speakers:
•    Karen Paese, Director, Clinical Supply Chain Management, Gilead Sciences
•    Richard Horn, Director, Clinical Supplies, Nektar Therapeutics
•    Robert Bottome, Executive Director, Global Supply Chain, BioMarin Pharmaceuticals
•    William Goure, Chief Operating Officer, Acumen
•    Louie Burks, Clinical Supply Manager, Exelixis
•    John Simons, Director of Clinical Quality Assurance, Gilead Sciences

For more information, please visit: http://www.arena-international.com/ctswest?clearcache=1 or alternatively email us at: events@arena-international.com

Global Engage is pleased to announce the 2018 Global Bioprocessing and Bioanalytics Congress, which will be held on 24th – 25th May 2018 in Prague, Czech Republic. The event is part of our highly successful series of life science technology congresses including conferences on Biologics & Biosimilars, Pharma R&D Informatics, qPCR and Digital PCR, Medicinal Chemistry, NASH and Precision Medicine amongst others.

The conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations, a high-level panel discussion, a roundtable discussion session, and interactive Q&A sessions from a 40-strong speaker faculty examining topics on 4 separate tracks outlined below.

Following on from its huge success in 2017, Oxford Global are proud to present their 3rd Annual Advances in Immuno-Oncology Congress, 24-25 May, London, UK. This event will host over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

Some of the world’s most leading authorities in Immuno-Oncology will give over 50 presentations across 6 interactive streams, including;

•    Discovery of Immuno-Oncology Therapies
•    Translational Immuno-Oncology
•    Genomics in Cancer Immunotherapy and Precision Medicine
•    Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
•    Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
•    Microbiome in Immuno-Oncology

SMi's 3rd Annual Pre-Filled Syringes West Coast 2018 Conference and Exhibition returns to San Diego on the 4th and 5th of June 2018

Following on from sell-out shows in Europe and Boston, Pre-Filled Syringes West Coast will gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase cutting edge advancements, keeping you at the forefront of a booming industry.

The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level, making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing in the landscape of complex biologics, whilst honing in on emerging trends for parenteral devices, in the remit of quality controls, intellectual property and advances in drug-delivery designs including auto injectors, pens, pumps and smart devices.

Aimed at forward-thinking individuals and businesses, FlyPharma’s series of conferences (Asia, Europe and US) will assemble a plethora of industry experts to address and examine the pharma supply chain’s hot (and cold!) topics in a lively and motivational manner.

With content that promises to be candid, contentious and challenging, these events have been conceived as a completely fresh approach to the pharma cargo sector. FlyPharma‘s objective is to highlight common industry logistics issues and, by doing so, stimulate a more inclusive dialogue among various supply chain stakeholders.

Each conference is unique and individual, tailored to the needs and issues of the pharma and cargo companies that work in each region but with a view to wider industry themes.

FlyPharma Europe will bring together a global audience of logistics and pharma professionals to dissect the latest regional and global supply chain topics, whilst providing a great opportunity to network with the sectors’ brightest minds.

Find out more about all of our conferences at www.FlyPharmaConference.com

FlyPharma Asia – 5-6 March 2018, Hong Kong
FlyPharma Europe – 5-6 June 2018, Brussels, Belgium
FlyPharma US – 11-12 September 2018, Miami, Florida

International Conference on Pharmaceutical Research and Development (Pharma Research 2018) scheduled to be held during June 06-07, 2018, Philadelphia, Pennsylvania, USA. The Pharma Research 2018 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Pharma Research 2018 International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements.

ConferenceSeries.com hosts 3000+ Global Events that includes over 600+ International Conferences, 1200+ Symposiums and 1200+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.

SMi proudly presents the 2nd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on the 7th and 8th of June 2018.

The pharmaceutical microbiology field is an ever-present constant in almost all areas of pharmaceuticals. Therefore, professionals within the field need to be informed and updated on the revised regulations and newly emerging methods and practices.

Join us to discuss and address the evolving issues facing this industry, such as: the aseptic practice and contamination prevention, mycoplasma testing, water monitoring and biofilms.

Oxford Global are proud to present their 19th Annual Drug Discovery Summit, 7-8 June, Berlin, Germany. This event will host over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Distinguished speakers will deliver over 20 presentations and case studies focused on the key issues in discovery chemistry and drug design. There will be 2 streams over the 2 days of the congress featuring;
 

• Day 1
         Part 1: Discovery Chemistry, Medicinal and Computational Chemistry
         Part 2: Drug Discovery Enabled Technologies; DNA Encoded Libraries
• Day 2
         Medicinal Chemistry and Drug Design: Novel Approaches
   

This event will also once again be co-located with 19th Annual Drug Discovery Summit and also the 2nd Annual Microbiome Discovery and Development Congress.

Free Webinar Recordings

Drug Discovery Open Innovation & Outsourcing
Patrick Kleyn, Director of Drug Target Innovation, EMD Serono

Phenotypic Screening in Drug Discovery – Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC, School of Life Sciences, Dundee & Dr. Joost Uitdehaag, Senior Investigator at Netherlands Translational Research Center B.V

DIsruptice Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals

To download these webinars click here: http://bit.ly/2nxL5SB

For further information, prices & discounts please contact g.alonso@oxfordglobal.co.uk or click here: http://bit.ly/2jZlzRi

Alternatively visit our website http://bit.ly/2iwyfyU

Oxford Global are proud to present their 2nd Annual Microbiome Discovery and Development Congress, 7-8 June, Berlin, Germany. This event will host over 350 microbiome and drug discovery attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

Distingguished speakers will deliver over 20 presentations and case studies focused on new technologies for microbiome drug discovery and the development and commercialisation of microbiome therapeutics. There will be 2 streams over the 2 days of the congress featuring;

•    Novel Strategies & Technologies for Microbiome Drug Discovery
•    Therapeutic Potential of the Microbiome

New for 2018, we also have an interactive workshop on commercialising microbiome therapeutics.

Today, the pharmaceuticals industry struggles to ensure the integrity of its products as they are transferred between the different parts of the supply chain from contract manufacturers to wholesalers to dispensers and ,finally, to the patient. This is particularly true as products move across international borders encountering various regulatory nuances and geography-specific threats. With infant mortality rates down and life expectancy up, our population is poised to grow exponentially increasing the need for drugs and therefore putting pressure on manufacturers to provide safe, reliable and effective drugs. Counterfeiting, product theft and public health are real concerns that need serialization solutions. 

To make matters more challenging, global data standards are still evolving in major markets like China, the EU and the US making global, regulatory compliance very difficult in the looming shadow of US Federal Drug Supply Chain Security Act (DSCSA) and Drug Quality and Security Act of 2013 (DQSA) compliance. Most importantly, it is imperative we look towards the future of emerging technologies like Blockchain, Electronic Product Code Information Services (EPCIS), GS1, barcoding, and the reality of better business decisions in aggregation to get ahead and not just play catch-up.

Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “8th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR” (Regulatory Affairs 2018) scheduled to be held during June 08-09, 2018 at Philadelphia, USA. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Regulatory Affairs, Manufacturing of pharmaceuticals in pharmaceuticals development.

Conference Theme: “Regulatory considerations in pharmaceutical & biopharmaceutical research and market”.

Regulatory Affairs 2018 is a unique platform to meet fellow key decision makers and experts all-around the Pharmaceutical, Biotech, Biomedical, Academic Institutions, Healthcare Institutes, regulatory scientists, regulatory professionals, quality analysts, formulation scientists and researchers making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world.

The SMi Group are pleased to announce their 5th Drug Safety Conference, taking place on the 11th – 12th June 2018 in Central London.

For any drug, anywhere, its safety in patients is a huge issue that is constantly under surveillance, irrespective of where the drug is in its pipeline.

The Global Pharmaceutical Market currently has a market value of $1057 billion. If a drug is found to be unsafe, causing serious side effects, it can have a huge knock on effect on revenue, causing huge losses to pharmaceutical companies manufacturing the drug.

Therefore, Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital and much awaited Clinical Trial Regulations. For more information, please see the benefits of attending or download our brochure!

Pharmaceutical companies are turning to their medical affairs function to boost interactions with critical payer groups such as Accountable Care Organizations and Integrated Delivery Networks. As value-based drug contracting between manufacturers and payers continue to move forward, and the healthcare industry turns away from fee-for-service, public and private payers are pushing providers to take on more financial accountability for their services through alternative payment models.

The 11th Partnering with ACOs & IDNs Summit will provide a platform for collaboration to advance ACO, IDN, and life sciences partnerships in population health management. Methods of information-exchange will include detailed presentations, collaborative panel discussions, and an interactive dinner.

The growing biotech industry has led to an increasingly competitive and saturated marketplace, and with it, greater competition for face time with premier thought leaders. Coupled with the scrutiny associated with industry partnerships and the challenges of managing KOL relationships in a post-Sunshine Act world, it is imperative for life science organizations to differentiate themselves from their competitors in the marketplace while aligning company objectives across their internal organization.

The 9th KOL/Thought Leader Engagement and Advisory Boards Summit will provide attendees with valuable insights into engaging traditional and non-traditional KOLs and discuss the priorities and motivating factors for patient groups, payers and managed care organizations. Join our esteemed faculty as they share disruptive techniques for attracting external stakeholders in meaningful ways and discuss strategies for commercial and medical groups to work together while maintaining compliance.

9th Digital Pharma West Is the Number-One Provider of Content, Innovation and Practical Insights on the West Coast. For 2018, we have spent a great deal of time conducting research and recruiting speakers from organizations of ALL sizes. We've found that, regardless of their company size, life science marketers struggle with how to effectively, efficiently and compliantly deliver an optimal customer experience. However, certain challenges are universal. At Digital Pharma West, we will explore these themes, delve into relevant questions and provide solutions to help overcome obstacles in your everyday business.

Oxford Global Conferences are proud to present the 2nd Annual Precision Medicine Congress, taking place in Munich, Germany. Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine.

There will be over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.

4 interactive streams:

•    Precision Medicine, Regulation, Reimbursement and Targeted Therapy
•    Precision Medicine, Biomarkers and Clinical Development
•    Precision Medicine: Genomics, Data analysis and Big Data Management
•    Precision Medicine and Diagnostics Development

This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field.

In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge between the key stakeholders from clinical trial transparency, disclosure, publications, data anonymisation, medical writing and medical affairs teams in preparing and executing policy 0070 submissions, ensuring compliance with GDPR, understanding data anonymisation standards, evaluating the effects of Brexit and the move of the EMA on data transparency, and building compliant processes in alignment with other global regulations including EU Clinical Trials Regulation and U.S. FDAAA Final Rule.

Join us at this critical time of change in the global clinical trials landscape to benchmark with peers on the ever-evolving transparency requirements to develop the most widely accepted and efficient best practices.

Clinical Trial Supply Southern California returns for another year to La Jolla, San Diego. Once again this event promises to deliver some of the most cutting edge content in the world of Clinical Trial Supplies tailored specifically for the industry in SoCal.

Standout speakers for 2018 include those from Receptos, Intercept and Pacira Pharma. On top of this, the event features some innovative biotech companies from the local area including Valley Fever Solutions and Spectrum Pharma.

Looking to 2018, with important regulatory changes inbound in the form of Annex 16 & Annex 6, the event will surely prove an ideal meeting place for the industry to discuss organisational changes which will be brought on by the changing industry landscape.

Agenda Highlights:
•    Early development of modern biologics and cell therapy products through global CMOs
•    Evaluating your inspection readiness strategy to guarantee you are on top of the changing clinical supply chain landscape and ready to comply with FDA
•    Outlining challenges in the import and export of IMP’s to guarantee drugs reach their destination and avoid delays at border control
•    Examining ways to select outsourcing partners from a small biotech perspective whilst staying on budget

Key Speakers:
•    Kelly Dawson, Senior Director, Clinical Supply Chain, Receptos
•    Vadim Klyushnichenko, Ph.D., Vice President Pharmaceutical Development & Quality, California Institute for Biomedical Research
•    Anthony Ororz, Assistant Director, Pharmaceuticals & Chemicals Center for Excellence & Expertise, US Borders and Customs
•    Francis Dumont, Senior Director, Drug Product Supply Sourcing, Pfizer

For more information, please visit: http://www.arena-international.com/ctssocal  or email us at: events@arena-international.com

Following the success of the CRISPR Congress in Boston and the launch of CRISPR Congress in Berlin, we are now building a CRISPR community on the West Coast for the genetic/gene editing research community in addition to getting into the burgeoning stem cell market

The inaugural Precision CRISPR Stem Cell Congress Seattle 12-14 June 2018, founded in partnership with the Allen Institute, will help the large pharma, biotech and academic community overcome efficiency, specificity and delivery challenges to optimise the application of CRISPR gene editing of stem cells.

Showcasing cutting edge data from key opinion leaders who are pushing the boundaries of CRISPR in both basic biological research and translational clinical development of stem cell therapies, discover how to enhance the technical protocols of CRISPR and overcome the scientific difficulties of editing human stem cells and iPS cells.

For its fifth edition, the NovAliX Conference "Biophysics in Drug Discovery" will be held for the first time in the US and will take place at the Hilton Back Bay in Boston, MA.

The use of biophysical methods has become pervasive in the drug discovery process, allowing not only to identify low-affinity hits at the screening stage but also to obtain detailed information on target / ligand interactions at more advanced stages (see the review Renaud et al. 2016 Nat. Rev. Drug Discov. 15: 679-698). This is perfectly illustrated by the success of FBDD (fragment-based drug design), where the progress of biophysical techniques in terms of sensitivity, speed, and automation has been instrumental (see the review Erlanson et al. 2016 Nat. Rev. Drug Discov. 15: 605-619). Indeed FBDD is now widely adopted in both academia and the pharmaceutical industry and has lead to 2 approved drugs and more than 30 compounds being evaluated in clinical trials.

Although an old process, Pharmaceutical Freeze Drying is ever evolving with new trends and approaches being used for pharmaceutical formulation. The 6th Annual Pharmaceutical Freeze Drying Technology conference will cover the most recent advances in Freeze drying technology and discuss the latest ideas in the industry. Join us in May to explore new approaches to prediction and analysis, alternative freeze drying technologies and overcome the challenges of freeze drying technology.

 Conference Series Ltd invites all the participants from all over the world to attend ‘10th World Congress on Medicinal Chemistry’ during June 14-15, 2018 at Barcelona, Spain, The main theme of the conference is Focus on present and future techniques and development in Medicinal Chemistry and Drug design which includes the prompt keynote presentations, Oral talks, Poster presentations, Video Presentations and Exhibitions.

Medicinal Chemistry is a global platform to discuss and learn about Medical research Advances in Medicinal Chemistry, Bioorganic and Medicinal Chemistry, Recent trends in Drug Design and Drug Development, Computational Chemistry, Pharmacology, Organic Chemistry, Analytical Chemistry, Chemical Biology, Anticancer agents in Medicinal Chemistry, Bio organometallic Chemistry and Toxicology, Biopharmaceuticals and Radiopharmaceuticals, Pharmaceutical Industry Trends, Pharmacotoxicology. Conference Series Ltd Conferences has taken the initiation to gather the world class experts both from academic and industry in a common platform.

ConferenceSeries Ltd invites all the participants from all over the world to attend ‘4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance' to be held on June 14-15, 2018 Barcelona, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

ConferenceSeries Ltd organizes a series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

International Conference on Pharmacology during June 18-20, 2018 at Tokyo, Japan. Pharmacology 2018 will focus on the theme “Research Advances in Pharmacological Field”.

Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. The key strategic objective of Meetings Int. is to communicate science and medical research between academia, and industry. We organize conferences world-wide. All major conferences of Meetings International are accredited with Continuing Professional Development (CPD), Continuing Education (CE), and Continuing Medical Education (CME) Credits.

In a new exciting development,  BOS 2018 will comprise the existing CMC focused event but in addition, will add a new discovery outsourcing component, creating an enlarged 2 day conference in Basel, Switzerland.

The new format will allow discovery and development teams the opportunity to come together to share experience and knowledge from discovery into development. For our CRO and CMO partners the addition of the discovery component to our existing CMC focused event will present an opportunity to engage with innovator companies at an earlier stage in the R&D continuum.

The 7th Annual HPAPI Summit will bring together perspectives from every stage of the drug development value chain – from bench to point of outsource – providing you with a unified outlook on the latest developments in highly potent compound development.

Incorporating insights from Pfizer, Genentech, Vertex, Biogen and Boehringer Ingelheim, this unique conference will delve into the scale-up, containment, risk-assessment, and outsourcing hurdles that need to be overcome to ensure your HPAPI development is robust, safe and cost-effective.

The Microbiome Drug Development Summit continues to be the industry leading forum that focuses exclusively on the development and commercialization of microbiome-based therapeutics; with case-studies from target discovery all the way through to clinical trial development, manufacturing and beyond.

Building on last year’s success, our CTS team have conducted extensive research to ensure the 2018 event programme covers all the essentials in clinical supply. In the current climate, every pharma and biotech company are trying to reduce unwanted costs, and enhance operational efficiency. To avoid costly setbacks, an innovative and effective strategy needs to be implemented!

Tailored to the Nordics region, the 5th annual conference will include highly relevant case studies, interactive roundtables and panel discussions, to assist you in your next strategic move. Find out what we have in store for you below:
 
2018 Agenda Highlights
•    Collaborating with CMOs to Ensure your Drug Reaches its Destination with No Excursions
•    Streamlining your Process Development in Early Phase Trials to Optimize Supplies Quality
•    Exploring Global Regulations to Fulfil any Potential Different Requirement in
All Foreign Sites
•    Pinpointing the Pros and Cons of Just In Time Planning for International Supply

2018 Key Speakers:
•    Francisco Rizzuto, Cargo Specialist Manager for Europe, IATA
•    Jonas Fransson, Director Drug Product Development, SOBI
•    Matti Lahde, Vice President, Production, FIT Biotech
•    Kjell-Are Furnes, CEO, Ably Medical

For more information on this year’s conference, please visit: http://www.arena-international.com/ctsnoridcs or email us at: events@arena-international.com

Combination product has been trending in the pharma market, and drug-device combo market is expected to reach $177.7 billion by 2024*.

The regulatory approval pathway for combo product isn’t the easiest, and maintaining market positions in such fierce competition is even more challenging for drug and device developers. A refined and innovative lifecycle management strategy plays a pivotal role to maximizing product longevity and commercial advantage.

As China's leading event for the pharmaceutical industry, P-MEC China strives to provide a platform for local, regional and international buyers, manufacturers, suppliers. Here, attendees meet, do business and drive research and development of the Chinese pharmaceutical machinery and equipment  industry.

Since its launch in 2010, P-MEC China has developed into one of the most comprehensive and pharma machinery and equipment focused events bringing the entire supply chain into one location via this series of co-located shows:
 

Now in its sixteenth consecutive year, CPhI China will take place from 21st to 23rd June 2016 at SNIEC, Shanghai, China and incorporate the events above. It will bring together over 35,000 experts from over 120 countries to shape the next chapter of China's pharma market.

Chemspec Europe is renowned for being a key market place for sourcing and trading of fine and speciality chemicals for a wide range of applications and industry sectors, including pharmaceuticals and bio-based chemicals. Chemspec Europe 2018 is held from 20th – 21st June 2018 at Koelnmesse in Cologne, Germany.

With its combination of an international exhibition, a comprehensive conference programme and targeted networking events, Chemspec Europe offers visitors a unique opportunity to source products, find business partners and keep up-to-date with the latest findings in R&D. The pharma conference themes at this year’s event include:

-    The Pharma Panel on Outsourcing Best Practices will be of interest to a wide audience from Pharma, Crop Protection and Chemical companies, CROs and CMOs who are engaged in contract research and custom synthesis of Active Pharmaceutical Ingredients (API). The sessions will discuss approaches to developing global outsourcing strategies, identifying outsourcing partners, identifying approaches to mitigate risks, and addressing challenges associated with outsourcing and how to effectively manage partnerships.

-    The Abou-Gharbia Lecture Theatre will focus on “Drug Discovery, Then and Now: The Road to Personalized Medicine” by Dr. Magid Abou-Gharbia, Moulder Center for Drug Discovery Research, School of pharmacy, Temple University, Philadelphia, PA, USA. The presentation will cover the themes “Discovery of Small Molecule Therapeutics”, “Companion Diagnostics and Targeted Therapies for Cancer” and “Precision Medicine’s Impact on Pharma and Health Care, Challenges and Future Opportunities.”

Details on the sessions in the Pharma Lecture Theatre at Chemspec Europe 2018 can be found here:
http://www.chemspeceurope.com/2018/english/conferences/pharma-lecture-theatre/

Global Engage is pleased to announce the Biologics & Biosimilars Congress: USA to be held in Boston, USA on June 21-22 2018.

Designed for experts working in a variety of exciting areas in biological therapeutics this conference will provide in-depth studies of antibody-based therapies, advances in immunotherapy and immuno-oncology, as well as developments in protein biotherapeutic considerations, techniques and technologies. Alongside this, our Biosimilars session will provide an opportunity to discuss the latest in the regulatory and commercial landscapes and a forum to examine the next steps in this ever-developing sector.

The Congress is expected to host over 50 presenters and several panel discussions and roundtable sessions, with opportunities for poster presentations, networking and 1-2-1 partnership meetings. This interactive meeting will provide the opportunity to keep up to date on the cutting edge of research and technology, new strategies and recent case study examples, and to forge lasting connections with other experts in your field.

The CAR-TCR Summit Asia is dedicated to the global delivery of safe, effective & commercially successful CAR-T and TCR cell therapies for liquid & solid tumor indications.

As the commercialization and approval of CAR-T therapies continues to gain momentum, the leaders are working to globalize the delivery of “curative” CAR-T and TCR therapies to beyond the Western world. Asia, as one of the world’s largest economies will serve as a cornerstone for the development and delivery of novel cellular immunotherapies.

Focused on ADC drug development, the inaugural World ADC Asia will enable you to propel your antibody-drug conjugate pipeline into clinical development.  Join 80+ ADC experts from the world’s leading ADC companies at this forum to network with potential collaborators and further cement existing partnerships.

ConferenceSeries Ltd is pleased to invite you to participate in the “12th World Congress on Biotechnology and Microbiology” to be held during July 28-29, 2018 Amsterdam, Netherlands with a theme “Current Advances & Innovative Research of Bio-Sciences”. ConferenceSeries Ltd organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

WCBM 2018 provides unique global opportunities for researchers and practitioners from all around the world to share the latest research and advancement in the field of Bioscience and learn from each other. Biotechnology & Microbiology includes the new research advances. Continuing education and advance practice are the step towards the achieving excellence in WCBM 2018. WCBM 2018 is a global platform to discuss and learn about exchange research evidence, innovative ideas and models of best practice. WCBM 2018 covers a wide range of Biotechnology & Microbiology research topics such Aquaculture & Marine Biotechnology, Agricultural Biotechnology, Medical Biotechnology, Industrial Biotechnology, Pure Microbiology, Medical Microbiology, Pharmaceutical Microbiology, Industrial Microbiology, Microbial Biotechnology, Food Microbiology, Biochemistry….. and many more. WCBM 2018 Organizing Committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers/practitioners to join us at Amsterdam, Netherlands for two days of stimulating discussions, knowledge sharing, and networking events.

Biocore takes immense pleasure & feel honored in inviting the contributors across the globe to attend the International Conference and Exhibition on Pharmaceutical Sciences & Research (Pharma-2018) during June 28-30, 2018 in Dubai, UAE.

This conference will have a variety of plenary lectures, session lectures, poster presentations, Scientific Exhibitions, Panel Discussions, and the B2B meetings with world renowned speakers, pharma and medical professionals, health care professionals and leading specialists involved in the field of pharmaceutical Sciences.

Pharma 2018 designed to provide a strong platform for Academic, Industrial Leaders, Business and Financial Executives to make experience exchanges around the world. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

The SMi group are thrilled to announce their 5th Molecular Diagnostics Conference! The meeting is convening in central London on 9th-10th July 2018, with two half-day post-conference workshops on 11th July 2018.

The global molecular diagnostics market is forecast to reach over $10 Billion USD in the next three years, at a CAGR of 9.1% from 2016 to 2021*. In this ever-evolving universe of molecular diagnostics, it is vital to keep up with emerging and developing technologies, products and applications. Furthermore, companies must comply to the constantly changing regulatory environment and tackle the challenging process of implementing these regulations.

Therefore, the SMi Group welcome you to explore the expanding market opportunities, latest diagnostic advancements and regulatory requirements at the 2-day conference.

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018.

Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.

The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

3rd International Conference on Ophthalmology invites all the members over the world to take part in the event with the theme “Enhancing the Quality and Credibility of Ophthalmology” which will be held in July 10-11, 2018 Bangkok, Thailand. World Ophthalmology 2018 conference will focus on most recent and energizing developments in territories of treating Ophthalmology diseases, Glaucoma, Diagnostics and Advances towards Eye Treatment. World Ophthalmology 2018 additionally goes about as a stage to trade data, new mediation and fortify the coordinated effort among Ophthalmologists, Specialists, Related Educators and Researchers from both Scholarly World and Ophthalmic Foundations.

3rd International Conference on Ophthalmology is organized by  ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field all over the globe.

International Pharma Supply Chain Confab, the region’s largest pharma specific supply chain gathering will enable attendees to share best practice on creating regionalised supply chains across the continent, taking into account specific issues such as temperature control, supply chain security, regulatory compliance and supplier management. This 2-day conference is the meeting place for life science supply chain heads responsible for growing and managing their company’s supply chains across the continent.

The programme focuses on providing pharmaceutical companies with regionalised and demand-driven strategies that ensure their product reach their customers safely and on-time.

There needs to be a fundamental shift in drug discovery and artificial Intelligence holds the key to bringing the pharma industry into the 21st Century. From discovery and development and through the entire product lifecycle, artificial intelligence (AI) is starting to shake up the life-sciences industry. The potential of intelligent apps (i.e., apps that are capable of learning from experience) is so far-reaching that it is expected that AI-enabled drugs will be brought to market in the near future. A Silicon Valley Bank analysis last month found that 44 venture-backed deals raised $2.2 billion between 2015 and the first half of 2017 for Dx/Tools companies that use AI/ML as part of their underlying technology. A report from Aruba states that 60 percent of health care organizations across the world have started using the internet of things in their facilities. Current uses include insulin delivery, activity trackers for cancer treatment, ingestible sensors, depression-fighting apps, and more.

Medical writers have the task of accurately understanding and summarizing complex information that ranges from scientific data in molecular biology and pharmacokinetics to statistical analysis plans and clinical outcomes. This data needs to be effectively shared in well-written, legible and compliant documents. Medical writers are also tasked with coordinating with internal stakeholders to get documents approved on time while receiving contributions from the right people. Because these documents are evaluated by regulatory agencies, it is vital for medical writers to stay up to date with the latest regulatory developments and anticipate how their documentation processes might be impacted.

The 5th Clinical Regulatory Medical Writing Forum is designed to provide attendees with the strategies and insights needed to efficiently compose clinical regulatory documents, manage in-house and external resources, effectively execute the writing process, and understand the recent developments in regulations.

Continued advances in understanding tumorigenesis and development have rapidly evolved the treatment paradigm. However, more and more therapeutics are being thrust into the clinic lacking robust and rational preclinical and translational validation. Unsurprisingly, attrition rates for cancer have remained appallingly high.

For the last 6 years the Tumor Models Conference has sat at the interface of innovation in model development and therapeutic application. It continues to serve as an open and collaborative platform enabling pharmaceutical scientists, model developers and academicians to explore recent advances in the range of in vitro and in vivo models being utilized for preclinical assessment and enhancing confidence in clinical translation of cancer research.

Following the tradition of successful Congresses held in several European countries, Dubai, Spain, Italy, India, South Africa and USA, the Organizing Committee of Conference Series Ltd is pleased to invite all the participants across the globe to attend the the “World Congress on Advanced Pharmacy and Clinical Research” during July 16-17, 2018 at Sydney, Australia.

The conference is a specially organized three days event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, Poster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Conference Series Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Real-world evidence can provide key insights that will help drive down medical costs, as well as improve both product safety and effectiveness. Unfortunately, the relevance and validity of user collected and practiced based real-world data is a challenge within the clinical health industry. If real-world data isn’t properly analyzed it can be tricky to utilize successfully. Companies must have an in-depth understanding of the data landscape and how to assess real-world data sources, analytics and applications to build real-world data platforms.

Proving safety and effectiveness through a randomized clinical trial no longer secure success and profitability of a drug or device. Companies must now demonstrate evidence of successful real-world outcomes to distinguish their products in an aggressive environment. While also fulfilling requests of regulators, insurance companies, healthcare providers, and patients.

Conferenceseries invites all the participants across the globe to attend the " Experts Meeting on Gynecologic Oncology”slated on July 18-19, 2018 at Atlanta, USA.

Annual conference on gynecologic oncology 2018 provides a forum of exchange of information among scientists, physicians and oncologists to present and discuss their Constructive, empirical, experimental, or theoretical work in every aspect of Gynecologic oncology thus upgrading the quality and administrations to the pertinent research works. Gynecology 2018 offer a front line program of prestigious worldwide speakers, pro simultaneous sessions, short paper and notice introductions drawing in more than 450 specialists in fruitfulness helped origination, sexual wellbeing and conceptive Science and Gynecology field. An extensive list of topics will be discussed that includes cervical cancer, ovarian cancer, uterine/endometrial cancer, Maternal Fetal Medicine, gynecology cancers, Endometriosis, preventive medicine oncology with the goal of improving the scientific network to all the concerned people to be a part of the conference and making it sensational with your presence.

ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth “16th International Conference and Exhibition on Pharmaceutical Formulations” (Formulation 2017) scheduled to be held during July 26-27, 2018 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Formulations.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Globally it’s estimated 1 in 5 people suffer from neuropsychiatric disorders. This figure, combined with drugs that are showing little or no response is making neuropsychiatric disorders  a huge unmet clinical need.

The neuropsychiatric drug development field has been stifled for decades by a lack of scientific progress in understanding the brain and costly and challenging clinical trials.

The tide is now starting to turn. Rapid scientific progress in identifying novel targets, discovering differentiated mechanisms of drug action and our ability to  develop ‘fast acting’ therapeutics has brought renewed enthusiasm to the field and investment is pouring in.

Indian Pharma Expo (IPE) will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries. The 3-day expo will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries. IPE is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnels who seek to buy bulk products on concessional rates.